Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “AstraZeneca”
Sponsor: AstraZeneca
Solid Tumours
United States, Australia, Japan, South Korea, Spain +1 more
Sponsor: Canadian Cancer Trials Group
Hepatocellular Carcinoma
Canada
- A Study to Evaluate the Safety and Pharmacokinetics of Ceralasertib in Combination With Durvalumab in Chinese Patients With Advanced Solid TumoursActive Not Recruiting
Sponsor: AstraZeneca
Advanced Solid Tumours
China
Sponsor: AstraZeneca
Endometrial Cancer
United States, Australia, Austria, Belgium, Brazil +18 more
- The Anifrolumab PRIM ProgramRecruiting
Sponsor: AstraZeneca
Systemic Lupus Erythematosus
Sweden
- A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With Clinical ASCVD or at Risk for a First ASCVD EventActive Not Recruiting
Sponsor: AstraZeneca
Cardiovascular Disease
United States, Argentina, Australia, Brazil, Bulgaria +17 more
Sponsor: AstraZeneca
Bladder Cancer
Russia
Sponsor: AstraZeneca
Prostate Cancer
United States, Australia, Canada, China, Japan +3 more
Sponsor: AstraZeneca
Healthy Participants · Obesity
United States, United Kingdom
- An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)Active Not Recruiting
Sponsor: AstraZeneca
Breast Cancer, Early Breast Cancer
United States, Argentina, Australia, Austria, Belgium +39 more
- Study of DNA Damage, Angiogenesis, and PD-L1 Inhibitors in Advanced Solid TumorsActive Not Recruiting
Sponsor: University Health Network, Toronto
Mismatch Repair Proficient Colorectal Cancer · Pancreatic Adenocarcinoma · Leiomyosarcoma
Canada
Sponsor: AstraZeneca
Advanced Solid Tumors
United States, South Korea, Spain, United Kingdom
Sponsor: AstraZeneca
ER-Positive HER2-Negative Breast Cancer
United States, France, Germany, Italy, Poland +4 more
Sponsor: AstraZeneca
Breast Cancer
Oman, Qatar, Saudi Arabia, United Arab Emirates
Sponsor: AstraZeneca
Non-small Cell Lung Cancer
United States, Canada, China, France, Georgia +10 more
Sponsor: AstraZeneca
Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated IGHV
Australia, Canada, Turkey (Türkiye), United Kingdom
- Study of the Effect of Haemodialysis on the Pharmacokinetics, Safety, and Tolerability of Balcinrenone/DapagliflozinNot Yet Recruiting
Sponsor: AstraZeneca
Kidney Failure
United States
- Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular AtherostenosisActive Not Recruiting
Sponsor: University of Florida
Intracranial Arteriosclerosis · Stroke
United States
- A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.Not Yet Recruiting
Sponsor: AstraZeneca
Chronic Kidney Disease
United States, Argentina, Australia, Brazil, Bulgaria +27 more
Sponsor: AstraZeneca
Endometrial Cancer
Russia
- A Study of Outcomes in Chinese Patients Treated With Anifrolumab Who Have Active Mod-severe Systemic Lupus ErythematosusNot Yet Recruiting
Sponsor: AstraZeneca
Lupus Erythematosus, Systemic
China
Sponsor: AstraZeneca
B-cell Malignancies
United States, Australia, Canada, China, Denmark +5 more
- Implementation of Standardized Early Identification and Diagnosis for Transthyretin Amyloidosis (ATTR) in High-Risk PopulationsActive Not Recruiting
Sponsor: AstraZeneca
ATTR-CM
China
- A Trial of CHOP-R Therapy, With or Without Acalabrutinib, in Patients With Newly Diagnosed Richter's SyndromeActive Not Recruiting
Sponsor: University of Birmingham
Richter Syndrome
United Kingdom
- Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial CancerActive Not Recruiting
Sponsor: AstraZeneca
Endometrial Neoplasms
United States, Australia, Belgium, Brazil, Canada +17 more